Trial Profile
An Observational,retrospective,multicenter study assessing safety and tolerability of Fingolimod treatment in patients with Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 21 Nov 2016 New trial record